Prescription antifungal injection product recalled for out-of-specification assay
Sun Pharmaceutical is recalling Amphotericin B for Injection (50 mg vials) due to out-of-specification assay results. The recall affects 11,016 vials with lot numbers BAE0055A, BAE0056A, and BAE0068A distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for out-of-specification assay on an intravenous antifungal medication. No illnesses or injuries are reported in the source. This is a risk-of-harm product where injury has not yet been reported, fitting the rubric criterion for High severity.
Plain-English summary
Sun Pharmaceutical Industries is recalling Amphotericin B for Injection, 50 mg vials, due to test results showing the product does not meet required assay specifications. The affected lot numbers are BAE0055A, BAE0056A, and BAE0068A, all expiring March 2026. Approximately 11,016 vials have been distributed nationwide.
Amphotericin B is a prescription antifungal medication administered intravenously to treat serious fungal infections. An out-of-specification assay means the drug does not meet established standards for potency and purity, and therefore its safety and effectiveness cannot be assured.
This recall affects healthcare facilities and pharmacies that received these specific lot numbers. Healthcare providers should immediately locate and segregate affected vials. Patients currently receiving Amphotericin B from these lots should consult their healthcare provider about their treatment status.
Healthcare facilities and pharmacies should stop using all vials from the affected lots and contact their supplier regarding return or replacement of the recalled product.
The recalled product
- Product
- AMPHOTERICIN B (AMPHOTERICIN B)
- Brand
- AMPHOTERICIN B
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Injectable Antifungal
- Hazard
- assay-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: BAE0055A
- BAE0056A
- BAE0068A
- Exp. Date 03/2026
UPCs (1)
- 0362756233010
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27